Conférence : Engineering the fight against cancer

mardi 15 octobre 2019 | Activités

Organisée en collaboration avec l’axe Cancer : biologie, pronostic et diagnostic

Invité : Jonathan Bramson, Ph. D.

Professor, Department of Pathology and Molecular Medicine, McMaster University, Ontario
Vice-Dean, Research for the Faculty of Health Sciences, McMaster University, Ontario


15 octobre 2019, 12 h


local 2999

Résumé | Jonathan Bramson holds a Tier I Canada Research Chair in Translational Cancer Immunology and the John Bienenstock Chair in Molecular Medicine. The Bramson lab is focused on developing methods to direct cancer patients’ immune systems to attack their tumors. Currently, the lab is using synthetic biology methods to direct T cells against discrete tumor targets. Of note, the Bramson lab has created a novel chimeric receptor, known as the T cell antigen coupling (TAC) receptor that displays enhanced anti-tumor activity and reduced toxicity relative to conventional CARs in pre-clinical models. In his talk, Pr Bramson will introduce the novel chimeric receptor.


Un buffet froid sera servi sur place.

Conférence disponible en visioconférence.

Télécharger l'affiche

<< Retour à la liste des nouvelles